Pharmafile Logo
Pharmafocus logo
Advanced Search

Vedana Therapeutics

Showing 1 posts of 1 posts found.

Vedana emerges with $46m funding to advance next-generation migraine therapies

June 26, 2026
Research and Development Vedana Therapeutics, migraine therapies

Vedana Therapeutics has emerged from stealth with $46m in Series A financing to support development of a pipeline of investigational …

News
The Gateway to Local Adoption Series

Latest content

Vedana emerges with $46m funding to advance next-generation migraine therapies

June 26, 2026

Phase 1 study supports further development of inhaled respiratory therapy

June 25, 2026

PL BioScience appoints Maik Jornitz to Board of Directors

June 24, 2026

Axplora consolidates liver disease API manufacturing in India

June 23, 2026

Data suggests avapritinib improves quality of life for patients with mastocytosis

June 22, 2026